Holen Sie sich die Stockscreener-App
4.32
3.36%
-0.15
Handel nachbörslich:
4.36
0.04
+0.93%
Schlusskurs vom Vortag:
$4.47
Offen:
$4.31
24-Stunden-Volumen:
50,277
Relative Volume:
0.07
Marktkapitalisierung:
$6.22M
Einnahmen:
$3.50M
Nettoeinkommen (Verlust:
$-37.33M
KGV:
-4.32
EPS:
-1
Netto-Cashflow:
$-19.15M
1W Leistung:
-0.92%
1M Leistung:
-5.47%
6M Leistung:
-68.24%
1J Leistung:
-82.03%
1-Tages-Spanne:
$4.10
$4.46
1-Wochen-Bereich:
$4.10
$4.8985
52-Wochen-Spanne:
$3.55
$100.80
Hcw Biologics Inc Stock (HCWB) Company Profile
Firmenname
Hcw Biologics Inc
Sektor
Branche
Telefon
954-842-2024
Adresse
2929 N COMMERCE PKWY, MIRAMAR
Vergleichen Sie HCWB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
4.32 | 11.07M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Hcw Biologics Inc Aktie (HCWB) Neueste Nachrichten
What analysts say about HCW Biologics Inc. stockJaw-dropping returns - Autocar Professional
What drives HCW Biologics Inc. stock priceConsistent triple returns - jammulinksnews.com
Why HCW Biologics Inc. stock attracts strong analyst attentionFree Access to Stock Community - Newser
Is HCW Biologics Inc. a good long term investmentExtraordinary profit generation - jammulinksnews.com
HCW Biologics : July 2025 - MarketScreener
HCW Biologics Soars 9.78% on Pipeline Advancements - AInvest
HCW Biologics Secures $7M License Fee Agreement with WY Biotech - AInvest
HCW Biologics Inc. Stock Analysis and ForecastHigh-profit trading signals - jammulinksnews.com
HCW Biologics Secures $7M License Fee Agreement - TipRanks
What institutions are buying HCW Biologics Inc. stock nowControlled Risk High Reward Plan - Newser
How HCW Biologics Inc. stock performs during market volatilityFree Best Performing Stock Alerts - Newser
What makes HCW Biologics Inc. stock price move sharplyFree Join Group - Newser
HCW Biologics (NASDAQ:HCWB) Stock Price Down 0.7% – What’s Next? - Defense World
HCW Biologics Advances Alopecia Areata Treatment with New Phase 1 Study - TipRanks
Insiders Re-Evaluate Their US$3.05m Stock Purchase As HCW Biologics Falls To US$6.9m - Yahoo Finance
HCW Biologics announces full exercise of pre-funded warrants by Armistice Capital - Investing.com
HCW Biologics Completes Warrant Exercise with Armistice - TipRanks
HCW Biologics develops new T-cell engagers for pancreatic cancer By Investing.com - Investing.com Canada
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements - GlobeNewswire
HCW Biologics regains compliance with Nasdaq listing requirements - Investing.com
HCW Biologics Board Member Resignation and Director Elections - TipRanks
HCW Biologics (NASDAQ:HCWB) Rating Lowered to “Sell” at Wall Street Zen - Defense World
HCW Biologics Sees Strong Investor Interest in June - TipRanks
HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Down 85.9% in May - Defense World
HCW Biologics (NASDAQ:HCWB) Trading Down 7.6% – Here’s What Happened - Defense World
Wall Street Zen Upgrades HCW Biologics (NASDAQ:HCWB) to “Hold” - Defense World
HCW Biologics Meets Nasdaq Listing Requirements in May 2025 - TipRanks
Finanzdaten der Hcw Biologics Inc-Aktie (HCWB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):